wr 1065 has been researched along with Injuries, Radiation in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (14.29) | 18.2507 |
| 2000's | 4 (57.14) | 29.6817 |
| 2010's | 2 (28.57) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Allison, RR; Benhabib, SM; Johnke, RM; Lee, TK; O'Brien, KF; Sheng, C; Wang, T; Wang, W | 1 |
| Ben-Josef, E; Chen, J; Ensminger, W; Feng, M; Feng, MR; Knol, JA; Lawrence, TS; Lu, Z; Normolle, DP; Pan, CC; Smith, DE | 1 |
| Bachy, CM; Cassatt, DR; Fazenbaker, CA; Kifle, G | 3 |
| Koukourakis, MI | 1 |
| Vos, O | 1 |
3 review(s) available for wr 1065 and Injuries, Radiation
| Article | Year |
|---|---|
Preclinical studies on the radioprotective efficacy and pharmacokinetics of subcutaneously administered amifostine.
Topics: Amifostine; Animals; Biological Availability; Cytoprotection; Drug Evaluation, Preclinical; Injections, Intravenous; Injections, Subcutaneous; Macaca fascicularis; Mercaptoethylamines; Radiation Injuries; Radiation-Protective Agents; Rats | 2002 |
Amifostine: is there evidence of tumor protection?
Topics: Amifostine; Animals; Antineoplastic Agents; Clinical Trials as Topic; Combined Modality Therapy; Dogs; Drug Evaluation, Preclinical; Humans; Mercaptoethylamines; Models, Animal; Neoplasms; Organoplatinum Compounds; Radiation Injuries; Radiation-Protective Agents; Rats; Sarcoma | 2003 |
Effects of dose and schedule on the efficacy of ethyol: preclinical studies.
Topics: Amifostine; Animals; Injections, Intravenous; Injections, Subcutaneous; Macaca fascicularis; Mercaptoethylamines; Models, Animal; Mucous Membrane; Radiation Injuries; Radiation-Protective Agents; Rats | 2003 |
2 trial(s) available for wr 1065 and Injuries, Radiation
| Article | Year |
|---|---|
Radioprotective effect of American ginseng on human lymphocytes at 90 minutes postirradiation: a study of 40 cases.
Topics: Adult; Antioxidants; DNA Damage; Female; Ginsenosides; Humans; Lymphocytes; Male; Mercaptoethylamines; Micronuclei, Chromosome-Defective; Micronucleus Tests; Middle Aged; Oxidative Stress; Panax; Phytotherapy; Plant Extracts; Radiation Injuries; Radiation-Protective Agents; Radiation, Ionizing; Reactive Oxygen Species; Single-Blind Method | 2010 |
A phase I clinical and pharmacology study using amifostine as a radioprotector in dose-escalated whole liver radiation therapy.
Topics: Adult; Aged; Amifostine; Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Carcinoma, Hepatocellular; Cholangiocarcinoma; Female; Humans; Liver; Liver Neoplasms; Logistic Models; Male; Maximum Tolerated Dose; Mercaptoethylamines; Middle Aged; Organs at Risk; Prospective Studies; Radiation Dosage; Radiation Injuries; Radiation Tolerance; Radiation-Protective Agents; Radiotherapy Planning, Computer-Assisted; Radiotherapy, Conformal | 2012 |
2 other study(ies) available for wr 1065 and Injuries, Radiation
| Article | Year |
|---|---|
Subcutaneous administration of amifostine (ethyol) is equivalent to intravenous administration in a rat mucositis model.
Topics: Amifostine; Animals; Female; Injections, Intravenous; Injections, Subcutaneous; Mercaptoethylamines; Models, Animal; Mouth Mucosa; Radiation Injuries; Radiation-Protective Agents; Rats; Rats, Sprague-Dawley; Stomatitis; Xerostomia | 2003 |
Role of endogenous thiols in protection.
Topics: Amifostine; Animals; Cells; Cysteamine; DNA Damage; DNA Repair; Free Radical Scavengers; Glutathione; Humans; Mercaptoethylamines; Prostaglandins; Radiation Injuries; Radiation Tolerance; Radiation-Protective Agents; Radiation, Ionizing; Sulfhydryl Compounds | 1992 |